Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

366 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Growth Hormone Research Society perspective on the development of long-acting growth hormone preparations.
Christiansen JS, Backeljauw PF, Bidlingmaier M, Biller BM, Boguszewski MC, Casanueva FF, Chanson P, Chatelain P, Choong CS, Clemmons DR, Cohen LE, Cohen P, Frystyk J, Grimberg A, Hasegawa Y, Haymond MW, Ho K, Hoffman AR, Holly JM, Horikawa R, Höybye C, Jorgensen JO, Johannsson G, Juul A, Katznelson L, Kopchick JJ, Lee KO, Lee KW, Luo X, Melmed S, Miller BS, Misra M, Popovic V, Rosenfeld RG, Ross J, Ross RJ, Saenger P, Strasburger CJ, Thorner MO, Werner H, Yuen K. Christiansen JS, et al. Among authors: bidlingmaier m. Eur J Endocrinol. 2016 Jun;174(6):C1-8. doi: 10.1530/EJE-16-0111. Epub 2016 Mar 23. Eur J Endocrinol. 2016. PMID: 27009113 Free PMC article.
Detection of doping with human growth hormone.
Wu Z, Bidlingmaier M, Dall R, Strasburger CJ. Wu Z, et al. Among authors: bidlingmaier m. Lancet. 1999 Mar 13;353(9156):895. doi: 10.1016/S0140-6736(99)00775-8. Lancet. 1999. PMID: 10093984 No abstract available.
Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant.
Trainer PJ, Drake WM, Katznelson L, Freda PU, Herman-Bonert V, van der Lely AJ, Dimaraki EV, Stewart PM, Friend KE, Vance ML, Besser GM, Scarlett JA, Thorner MO, Parkinson C, Klibanski A, Powell JS, Barkan AL, Sheppard MC, Malsonado M, Rose DR, Clemmons DR, Johannsson G, Bengtsson BA, Stavrou S, Kleinberg DL, Cook DM, Phillips LS, Bidlingmaier M, Strasburger CJ, Hackett S, Zib K, Bennett WF, Davis RJ. Trainer PJ, et al. Among authors: bidlingmaier m. N Engl J Med. 2000 Apr 20;342(16):1171-7. doi: 10.1056/NEJM200004203421604. N Engl J Med. 2000. PMID: 10770982 Free article. Clinical Trial.
Acromegaly caused by secretion of growth hormone by a non-Hodgkin's lymphoma.
Beuschlein F, Strasburger CJ, Siegerstetter V, Moradpour D, Lichter P, Bidlingmaier M, Blum HE, Reincke M. Beuschlein F, et al. Among authors: bidlingmaier m. N Engl J Med. 2000 Jun 22;342(25):1871-6. doi: 10.1056/NEJM200006223422504. N Engl J Med. 2000. PMID: 10861322 Free article. No abstract available.
Test method: GH.
Bidlingmaier M, Wu Z, Strasburger CJ. Bidlingmaier M, et al. Baillieres Best Pract Res Clin Endocrinol Metab. 2000 Mar;14(1):99-109. doi: 10.1053/beem.2000.0057. Baillieres Best Pract Res Clin Endocrinol Metab. 2000. PMID: 10932814 Review.
Changes in non-22-kilodalton (kDa) isoforms of growth hormone (GH) after administration of 22-kDa recombinant human GH in trained adult males.
Wallace JD, Cuneo RC, Bidlingmaier M, Lundberg PA, Carlsson L, Boguszewski CL, Hay J, Boroujerdi M, Cittadini A, Dall R, Rosén T, Strasburger CJ. Wallace JD, et al. Among authors: bidlingmaier m. J Clin Endocrinol Metab. 2001 Apr;86(4):1731-7. doi: 10.1210/jcem.86.4.7379. J Clin Endocrinol Metab. 2001. PMID: 11297610 Clinical Trial.
366 results